Hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome);Hereditární nepolypózní kolorektá lní karcinom (HNPCC1 Lynchův syndrom)

Klinicka Onkologie

Volumn 22, Issue SUPPL., 2009, Pages

  Plevová, Pavlína ^a,b   Novotny J ^c   Sachlova M ^c   Krepelova A ^d   Foretova L ^c  

^a UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^d UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL CARCINOMA; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; REVIEW; TRANSVAGINAL ECHOGRAPHY;

COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; GENETIC TESTING; HUMANS;

EID: 67650872601     PISSN: 0862495X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Aarnio M, Mecklin JP, Aaltonen LA et al. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995; 64: 430-433. (Pubitemid 26048907)
2. Aarnio M, Sankila R, Pukkala E et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999; 81: 214-218. (Pubitemid 29144749)
3. Foretová L, Šachlová M, Křepelová A. Genetické poradenství a testování u rodin s dědičným rizikem kolorek- tálního karcinomu. Čes a Slov Gastroent a Hepatol 1999; 53 (Suppl): 84-85.
4. Franková V, Židovská J, Krutilková V et al. Psychosociální faktory spojené s genetickým testovánim, některých dědičné podmíněných nádorových onemocně ní. Čas Lék Česk 2003; 14(10): 599-602. (Pubitemid 37328647)
5. Goetz P, Krutílková V. Kancerogeneze. Postgrad Med 2002; 4(5): 544-551.
6. Green SE, Bradburn DM, Varma JS et al. Hereditary non polyposis colorectal cancer. Int J Colorect Dis 1998; 13: 3-12. (Pubitemid 28241380)
7. Hodgson SV, Foulkes WD, Eng Ch et al. A Practical Guide to Human Cancer Genetics. Cambridge: University Press 2007.
8. http://www.nccn.org
9. Chen LM, Yang KY, Little SE et al. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families. Obstet Gynecol 2007; 110: 18-25. (Pubitemid 47015695)
10. Kleibl Z, Havranek O, Hlavata I et al. The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population. Eur J Cancer 2009; 45(4): 618-624.
11. Krutílková V, Havlovicová M, Goetz P. Specializované genetické poradenství u dětský ch a dospělých onkologických pacientů. Čas Lék Česk 2002; 141(1): 23-27.
12. Křepelová A, Pavlíková K, Plevová P. Diagnostika Lynchova syndromu - nové geny a metody. Klin Onkol 2006; 19 (Suppl): 76-81. (Pubitemid 44759784)
13. Lindor NM, Rabe K, Petersen GM et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005; 293: 1979-1985. (Pubitemid 40570891)
14. Plevová P, Bouchal J, Fiurásková M et al. PML and TRF2 protein expression in hereditary and sporadic colon cancer. Neoplasma 2007; 54(4): 269-277.
15. Plevová P, Křepelová A, Papežová M et al. Immunohistochemical Detection of the hMLH1 and hMSH2 Proteins in Hereditary Non-Polyposis Colon Cancer and Sporadic Colon Cancer. Neoplasma 2004; 51 (3): 204-208. (Pubitemid 38915545)
16. Plevová P, Sedláková E, Zapletalová J et al. Expression of the hMLH1 and hMSH2 Proteins in Normal Tissues in Relationship to Cancer Predisposition in Hereditary Non-polyposis Colon Cancer. Virchows Arch 2005; 446(2): 112-119. (Pubitemid 40385640)
17. Plevová P, Šilhánová E, Foretová L. Vzácné hereditární syndromy s vyšš ím rizikem vzniku nádorů. Klin Onkol 2006; 19 (Suppl): 68-75.
18. Plevová P, Sedláková E, Papežová M et al. Epidermal Growth Factor Receptor Expression in Colorectal Tumors with and without Microsatellite Instability. Virchows Arch 2004; 445(1): 99-100. (Pubitemid 39044279)
19. Pratt CB, Parham DM, Rao BN et al. Multiple colorectal carcinomas, polyposis coli and neurofibromatosis. J Natl Cancer Inst 1988; 80: 1170-1172. (Pubitemid 18240735)
20. Ricciardome MD, Özcelik T, Cevher B et al. Human MLH1 deficiency predisposes to hematological malignancy and nerofibromatosis type I. Cancer Res 1999; 59: 290-293. (Pubitemid 29048854)
21. Šachlová M, Foretová L. Střevní polypózní syndromy a dědičnost kolorektá lního karcinomu. Klin Onkol 1998; 11(4): 107-111.
22. Umar A, Boland CR, Terdiman JP et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96: 261-268. (Pubitemid 38256271)
23. Vasen HF, Mecklin JP, Khan PM et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34: 424-425.
24. Vasen HF, Watson P, Mecklin JP et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116: 1453-1456. (Pubitemid 29258894)
25. Vasen HFA, Möslein G, Alonso A et al. Guidelines fo the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 2007; 44: 353-362. (Pubitemid 46953715)
26. Watson P, Lynch PT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993; 71: 677-685. (Pubitemid 23051366)
27. Watson P, Vasen HF, Mecklin JP et al. The risk of endometrial cancer in hereditary non polyposis colorectal cancer. Am J Med 1994; 96: 516-520. (Pubitemid 24184436)